Skip to main content Skip to search Skip to main navigation
 Get a free Melatonin Spray with purchases over €100  Get a free Melatonin Spray with purchases over €100 X
Menu
Premium Nahrungsergänzungsmittel | artgerecht

Cenobamate - Antiepileptic Drug for Focal Seizures

Cenobamate is an antiepileptic drug used to treat focal seizures in adults. It acts on sodium channels and GABA-A receptors in the brain.

Regular tips about health Regular tips about health
Lexicon Navigation

Things worth knowing about "Cenobamate"

Cenobamate is an antiepileptic drug used to treat focal seizures in adults. It acts on sodium channels and GABA-A receptors in the brain.

What is Cenobamate?

Cenobamate is a prescription antiepileptic drug (AED) approved for the treatment of focal (partial) seizures in adults. It is marketed under the brand name Xcopri in the United States and Ontozry in Europe. Cenobamate is indicated as add-on therapy for patients whose seizures have not been adequately controlled by other antiepileptic medications.

Indication

Cenobamate is approved for:

  • Focal seizures with or without secondary generalization in adults
  • Drug-resistant epilepsy, meaning cases where at least two prior antiepileptic treatments have failed to provide sufficient seizure control

Mechanism of Action

Cenobamate works through two distinct mechanisms simultaneously, which distinguishes it from many other antiepileptic drugs:

  • Sodium channel blockade: Cenobamate inhibits voltage-gated sodium channels in the brain, particularly the persistent sodium current. This reduces the excessive electrical activity in neurons that triggers epileptic seizures.
  • GABA-A receptor modulation: Cenobamate enhances the activity of GABA (gamma-aminobutyric acid), the brain's primary inhibitory neurotransmitter, by binding to a specific site on the GABA-A receptor. This increases neuronal inhibition and reduces seizure activity.

This dual mechanism of action may explain why cenobamate can be effective even in patients with treatment-resistant epilepsy.

Dosage and Administration

Cenobamate is taken orally as a tablet. The dose is titrated gradually to reduce the risk of adverse reactions:

  • Starting dose: 12.5 mg once daily for 2 weeks
  • Dose increases every 2 weeks: 25 mg, then 50 mg, then 100 mg
  • Maintenance dose: typically 200 mg once daily; up to 400 mg once daily depending on tolerability and response

The slow titration schedule is critical to minimize the risk of serious adverse effects, particularly Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS syndrome).

Side Effects

Common side effects of cenobamate include:

  • Dizziness and coordination problems
  • Fatigue and somnolence
  • Headache
  • Diplopia (double vision) or blurred vision
  • Nausea

Rare but serious adverse effects include:

  • DRESS syndrome: A potentially life-threatening hypersensitivity reaction characterized by skin rash, fever, and organ involvement. The risk is significantly reduced by slow dose titration.
  • QT interval shortening on ECG (cardiac rhythm changes)
  • Elevated liver enzymes

Drug Interactions

Cenobamate can affect the plasma concentrations of other medications, as it is metabolized by hepatic enzymes including CYP3A4 and others. Clinically relevant interactions include:

  • Other antiepileptic drugs such as phenytoin, phenobarbital, and clobazam
  • Hormonal contraceptives (cenobamate may reduce their effectiveness)
  • Other drugs metabolized by CYP enzymes

Contraindications

  • Known hypersensitivity to cenobamate or any excipient
  • Familial Short QT syndrome
  • Pregnancy and breastfeeding (use only after careful benefit-risk assessment)

References

  1. European Medicines Agency (EMA): Ontozry (cenobamate) - Summary of Product Characteristics and Assessment Report. EMA/CHMP, 2021. Available at: www.ema.europa.eu
  2. Krauss GL et al. - Randomized Phase 2 Study of Cenobamate (YKP3089) as Adjunctive Treatment for Uncontrolled Focal Seizures. Neurology. 2020;91(14):e1289-e1298.
  3. Biton V et al. - Cenobamate for Uncontrolled Focal Seizures: A Randomized, Double-Blind, Placebo-Controlled Trial. Lancet Neurology. 2019;18(12):1027-1037.
artgerecht

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Verwandte Produkte

floral lactoferrin cln mundflora lutschtabletten?ts=1781276101

Average rating of 4.96 out of 5 stars

Floral

For Healthy Oral Flora & Dental Care

Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Sugar free
Lab tested
Non-GMO
Cologne List
Lactose free
Tooth friendly
GMP Quality
Clinical proofed
Pure CLN
30 lozenges
Regular price: €22.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.
lactoferrin 60 eisenbinder transporter kuhmilch?ts=1758111262

Average rating of 4.85 out of 5 stars

Lactoferrin

For your universal protection

As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Lactose free
[siehe Varianten]
Regular price: €59.90
natural iron supplement premium plantderived mineralcomplex?ts=1751927698

Average rating of 4.94 out of 5 stars

Natural Iron

For your iron balance

Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Gluten free
Lactose free
100% vegetarian fermentation
30 Capsules
30 Capsules
Regular price: €35.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.